Prevalence of E. Coli in Urinary Tract Infection of Children Aged 1-15 Years in A Medical College of Eastern Nepal.


Journal

JNMA; journal of the Nepal Medical Association
ISSN: 1815-672X
Titre abrégé: JNMA J Nepal Med Assoc
Pays: Nepal
ID NLM: 0045233

Informations de publication

Date de publication:
Jan 2020
Historique:
entrez: 27 4 2020
pubmed: 27 4 2020
medline: 18 2 2021
Statut: ppublish

Résumé

Urinary tract infection is one of the commonest causes of childhood morbidity. Early diagnosis and appropriate choice of antimicrobials is essential. Hence, this study aims to identify the prevalence of Escherichia coli in childhood urinary tract infections. This was a hospital based descriptive cross-sectional study conducted in Nobel Medical College, Biratnagar over a period of one year. A total of 163 cases aged 1-15 years were included and clinical profile, laboratory reports including bacterial isolates in urine cultures and their sensitivity patterns were documented. The prevalence of Escherichia coli is 45 (53.57%) C.I. Escherichia coli was the most common organism isolated in bacterial cultures followed by Klebsiella 12 (14.29%), Enterococcus 10 (11.90%). Urinary tract infection was common among females with male: female ratio of 1:2.3. Fever 152 (93.2%) and abdominal pain 113 (69.3%) were the most common presenting symptoms. Escherichia coli was found most sensitive to Nitrofurantoin 43 (95.5%) followed by Ciprofloxacin 41 (91.1%) and Amikacin 40 (88.8%). Urinary tract infections in childhood require prompt attention and treatment to prevent significant morbidity and mortality. From this study it can be concluded that Escherichia coli is one of the most common isolates in urine culture and Aminoglycosides and Fluoroquinolones can be accepted as empirical treatment regimens for childhood Urinary tract infections.

Identifiants

pubmed: 32335632
pmc: PMC7580475

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-14

Références

Indian J Med Res. 2010 Jan;131:101-5
pubmed: 20167982
Rev Esp Quimioter. 2001 Mar;14(1):63-8
pubmed: 11376352
J Clin Diagn Res. 2014 Oct;8(10):DC01-3
pubmed: 25478339
BMC Pediatr. 2019 Jan 29;19(1):36
pubmed: 30696410
Kathmandu Univ Med J (KUMJ). 2013 Oct-Dec;11(44):319-24
pubmed: 24899328
Nepal Med Coll J. 2011 Mar;13(1):24-6
pubmed: 21991696
FP Essent. 2020 Jan;488:25-34
pubmed: 31894953
Indian J Urol. 2016 Jan-Mar;32(1):50-6
pubmed: 26941495
Arch Pediatr. 2015 May;22(5):505-9
pubmed: 25842196
Medicine (Baltimore). 2015 Sep;94(39):e1606
pubmed: 26426643
Paediatr Int Child Health. 2017 Nov;37(4):273-279
pubmed: 28978286
Pan Afr Med J. 2017 Nov 23;28:258
pubmed: 29881501

Auteurs

Arun Giri (A)

Department of Pediatrics and Neonatology, Nobel Medical College Teaching Hospital, Biratnagar, Nepal.

Raju Kafle (R)

Department of Pediatrics and Neonatology, Universal College of Medical Sciences, Bhairahawa, Nepal.

Ganesh Kumar Singh (GK)

Department of Pediatrics and Neonatology, Nobel Medical College Teaching Hospital, Biratnagar, Nepal.

Niraj Niraula (N)

Department of Pediatrics and Neonatology, Nobel Medical College Teaching Hospital, Biratnagar, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH